ALDH1A1 and ovarian cancer: Together these data suggest that ovarian cancer stem-like cells may maintain therapeutic resistance by expressing ALDH1A1 and depletion of which, abrogates G1 and S-phase checkpoints (Figures 5A and 6C) leading to replication stress (Figure 5B).